期刊
INTERNATIONAL JOURNAL OF GENERAL MEDICINE
卷 14, 期 -, 页码 3793-3807出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJGM.S253177
关键词
deprescribing; polypharmacy; geriatric; older people; computerized clinical decision support; quality indicator
Deprescribing is an established strategy to reduce polypharmacy and potentially inappropriate medications in older people, but there is limited clinical evidence for its effectiveness on global and geriatric outcomes. Challenges at various levels of the healthcare system may impact the success of deprescribing interventions in research and practice, requiring comprehensive management strategies to overcome them. Future studies should consider large multicenter prospective designs to establish the effects and sustainability of deprescribing interventions on clinical outcomes.
Polypharmacy is a major challenge in healthcare for older people, and is associated with increased risks of adverse outcomes, such as delirium, falls, frailty, cognitive impairment and hospitalization. There is significant public and professional interest in the role of deprescribing in reducing medication-related harms in older people. We aim to provide a narrative review of 1) the safety and efficacy of deprescribing interventions, 2) the challenges and solutions of deprescribing research and implementation in clinical practice, and 3) the benefits of using Computerized Clinical Decision Support Systems (CCDSS) and Quality Indicators (QIs) in deprescribing research and practice. Deprescribing is an established management strategy to minimize polypharmacy and potentially inappropriate medications. There is limited clinical evidence for its efficacy on global and geriatric outcomes. Various challenges at patient, healthcare professional and healthcare system levels may impact on the success of deprescribing interventions in research and practice. Management strategies that target all levels of the healthcare system are required to overcome these challenges. Future studies may consider large multicenter prospective designs to establish the effects and sustainability of deprescribing interventions on clinical outcomes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据